Characterization of karyotypic events and evolution in neuroblastoma

被引:14
作者
Betts, DR
Cohen, N
Leibundgut, KE
Kühne, T
Caflisch, U
Greiner, J
Traktenbrot, L
Niggli, FK
机构
[1] Univ Childrens Hosp, Dept Oncol, CH-8032 Zurich, Switzerland
[2] Chaim Sheba Med Ctr, Dept Pediat Hematooncol, Ramat Gan, Israel
[3] Univ Childrens Hosp, Dept Haematol & Oncol, Bern, Switzerland
[4] Univ Childrens Hosp, Dept Haematol & Oncol, Basel, Switzerland
[5] Childrens Hosp, Dept Oncol, Luzan, Switzerland
[6] Childrens Hosp, Dept Oncol, St Gallen, Switzerland
关键词
cytogenetics; FISH; karyotypic evolution; neuroblastoma;
D O I
10.1002/pbc.20179
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Neuroblastoma (NB) is cytogenetically characterized by a number of non-random events. However, knowledge is limited concerning the timing Of Occurrence and interaction of many of these events. Methods. Karyotypic patterns were obtained from a study group of 49 NB tumors that had been analyzed by conventional cytogenetics combined with FISH and in some instances SKY. Results. All chromosomes were involved in a numerical and structural aberration in at least one tumor. There was a positive correlation between the Occurrence of MYCN and del(1p) and between cleft(1p) and 17q. Aberrations involving chromosomes X, 3, 19, and del(1p) could be considered early events, whereas those involving chromosomes 9, 13, 15, 18, 20, and 21 were often late events. Conclusions. This study suggests that the karyotypic patterns characterizing NB are complex. There are aberrations that can be grouped into early or late karyotypic events, but others, such as gain of l7q, are variable. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:147 / 157
页数:11
相关论文
共 43 条
[1]  
AVETLOISEAU H, 1995, CANCER, V75, P1694, DOI 10.1002/1097-0142(19950401)75:7<1694::AID-CNCR2820750721>3.0.CO
[2]  
2-Z
[3]   Routine karyotyping in Wilms tumor [J].
Betts, DR ;
Koesters, R ;
Pluss, HJ ;
Niggli, FK .
CANCER GENETICS AND CYTOGENETICS, 1997, 96 (02) :151-156
[4]   Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma [J].
Bown, N ;
Cotterill, S ;
Lastowska, M ;
O'Neill, S ;
Pearson, ADJ ;
Plantaz, D ;
Meddeb, M ;
Danglot, G ;
Brinkschmidt, C ;
Christiansen, H ;
Laureys, G ;
Speleman, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (25) :1954-1961
[5]   Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization [J].
Breen, CJ ;
O'Meara, A ;
McDermott, M ;
Mullarkey, M ;
Stallings, RL .
CANCER GENETICS AND CYTOGENETICS, 2000, 120 (01) :44-49
[6]   Neuroblastoma - Clinical Applications of Molecular Parameters [J].
Brodeur, Garrett M. .
BRAIN PATHOLOGY, 1990, 1 (01) :47-54
[7]   Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma [J].
Caron, H ;
vanSluis, P ;
deKraker, J ;
Bokkerink, J ;
Egeler, M ;
Laureys, G ;
Slater, R ;
Westerveld, A ;
Voute, PA ;
Versteeg, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (04) :225-230
[8]   COMPARISON OF DNA ANEUPLOIDY, CHROMOSOME-1 ABNORMALITIES, MYCN AMPLIFICATION AND CD44 EXPRESSION AS PROGNOSTIC FACTORS IN NEUROBLASTOMA [J].
CHRISTIANSEN, H ;
SAHIN, K ;
BERTHOLD, F ;
HERO, B ;
TERPE, HJ ;
LAMPERT, F .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (04) :541-544
[9]   Detection of unidentified chromosome abnormalities in human neuroblastoma by spectral karyotyping (SKY) [J].
Cohen, N ;
Betts, DR ;
Trakhtenbrot, L ;
Niggli, FK ;
Amariglio, N ;
Brok-Simoni, F ;
Rechavi, G ;
Meitar, D .
GENES CHROMOSOMES & CANCER, 2001, 31 (03) :201-208
[10]   SENSITIVE DETECTION OF NUMERICAL AND STRUCTURAL-ABERRATIONS OF CHROMOSOME-1 IN NEUROBLASTOMA BY INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION - COMPARISON WITH RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM AND CONVENTIONAL CYTOGENETIC ANALYSES [J].
COMBARET, V ;
TURCCAREL, C ;
THIESSE, P ;
REBILLARD, AC ;
FRAPPAZ, D ;
HAUS, O ;
PHILIP, T ;
FAVROT, MC .
INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (02) :185-191